Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial | Zendy

Andreas Pasch | Zendy; Geoffrey A. Block | Zendy; Matthias Bachtler | Zendy; Edward R. Smith | Zendy; Willi JahnenDechent | Zendy; Spyridon Arampatzis | Zendy; Glenn M. Chertow | Zendy; Patrick S. Parfrey | Zendy; Xiaoye Ma | Zendy; J. Floege | Zendy

Open Access

Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial

Author(s) -

Andreas Pasch,

Geoffrey A. Block,

Matthias Bachtler,

Edward R. Smith,

Willi JahnenDechent,

Spyridon Arampatzis,

Glenn M. Chertow,

Patrick S. Parfrey,

Xiaoye Ma,

J. Floege

Publication year - 2016

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04720416

Subject(s) - medicine , hazard ratio , hemodialysis , creatinine , confidence interval , myocardial infarction , clinical endpoint , unstable angina , confounding , cardiology , randomized controlled trial

Patients receiving hemodialysis are at risk of cardiovascular events. A novel blood test (T 50 test) determines the individual calcification propensity of blood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research